The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Solov'eva É.Iu.

Kafedra nevrologii FUV GOU VPO RGMU, Moskva

Mironova O.P.

Fedotova A.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH

Authors:

Fedin A.I., Solov'eva É.Iu., Mironova O.P., Fedotova A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(12): 104‑111

DOI: 10.17116/jnevro2014114121104-111

Read: 12805 times

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OF ASTHENIC SYNDROME IN PATIENTS WITH CHRONIC BRAIN ISCHEMIA: RESULTS OF THE NON-INTERVENTIONAL OBSERVATIONAL PROGRAM TRIUMPH
TREATMENT OF ASTHENIC SYNDROME IN PATIENTS WITH CHRONIC BRAIN ISCHEMIA: RESULTS OF THE NON-INTERVENTIONAL OBSERVATIONAL PROGRAM TRIUMPH

To cite this article:

Fedin AI, Solov'eva ÉIu, Mironova OP, Fedotova AV. Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(12):104‑111. (In Russ.)
https://doi.org/10.17116/jnevro2014114121104-111

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Study of the practice of prescribing phenosanic acid in epilepsy acco­mpanied by asthenic diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):89-97
Inte­grative asse­ssment of the effe­ctiveness and safety of outpatient use of Pica­milon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Como­rbid anxiety diso­rders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment stra­tegy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93

Objective. To assess the severity of asthenic syndrome (AS) in chronic brain ischemia (CBI) in primary health care settings. Material and methods. The study included 1170 patients with brain ischemia, aged 45-65 years, treated with phenotropil in dose 100 mg during 2 and 3 months. Clinical examination and MFI-20 subscales were administered. Results and сonclusion. The high incidence of asthenic syndrome was observed across all MFI-20 subscales. The decrease in asthenic syndrome severity was significant already in the end of the first month of treatment with phenotropil. Such dynamics maintained to the end of the second and third month of treatment. More than 2-fold decrease in the severity of asthenia symptoms was achieved in all subgroups 3 months after treatment. More rapid and apparent decrease in asthenic syndrome was observed in younger patients.

Keywords:

asthenic syndrome
chronic brain ischemia
MFI-20 questionnaire for asthenia
phenotropil

Authors:

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Solov'eva É.Iu.

Kafedra nevrologii FUV GOU VPO RGMU, Moskva

Mironova O.P.

Fedotova A.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

List of references:

  1. Skvortsova V.I. Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya. Consilium Medicum 2005; 07.
  2. Fedin A.I. Oksidantnyi stress i primenenie antioksidantov v nevrologii. Atmosfera. Nervnye bolezni 2002; 1: 15-18.
  3. Yakhno N.N., Zakharov V.V. Kognitivnye i emotsional'no-affektivnye narusheniya pri distsirkulyatornoi entsefalopatii. Rus med zhurn 2002; 10: 12-13: 539-542.
  4. Zakharov V.V. Khronicheskaya sosudistaya mozgovaya nedostatochnost'. Trudnyi patsient 2005; 12: 5.
  5. Skvortsova V.I., Stakhovskaya L.V., Gudkova V.V. i dr. Khronicheskaya ishemiya mozga. Consilium Medicum 2006; 1: 3.
  6. Gusev E.I., Konovalov A.N., Skvortsova V.I. i dr. Khronicheskaya nedostatochnost' mozgovogo krovoobrashcheniya. Nevrologiya: Natsional'noe rukovodstvo. M: GEOTAR-Media 2010.
  7. Fedin A.I. Izbrannye lektsii po ambulatornoi nevrologii. M 2013; 127.
  8. Vorob'eva O.V. Mnogogrannost' fenomena astenii. RMZh 2012; 5: 248-252.
  9. Abbot N.C. Chronic fatigue syndrome. Lancet 2006; 67: 9522.
  10. Zhmurov V.A. Bol'shoi tolkovyi slovar' terminov psikhiatrii. Elista: Dzhangar 2010; 864.
  11. Du Boistesselin R. Gaz Med 1988; 95: Suppl 3: 21-24.
  12. Feuerstein C. Neurophysiological data concerning fatigue. Role of activator reticular formation. Entretiens de Bichat 1992; 11-19.
  13. Avedisova A.S. Terapiya astenicheskikh sostoyanii. Farmatsevticheskii vestnik 2003; 3: 282: 15-16.
  14. Vorob'eva O.V. Astenicheskie sostoyaniya: effektivnaya i bezopasnaya terapiya. RMZh 2009; 20: 1330-1334.
  15. Bamdas B.S. Astenicheskie sostoyaniya. M: Meditsina 1961; 120.
  16. Avedisova A.S., Akhapkin R.V., Akhapkina V.I., Verigo N.N. Piratsetam v svete sovremennykh issledovanii (analiz zarubezhnykh issledovanii). Psikhiatriya i psikhofarmakoterapiya 2000; 2: 178-184.
  17. Shavlovskaya O.A. Terapiya astenicheskikh sostoyanii u bol'nykh, perenesshikh insul't. Farmateka 2013; 19: 56-61.
  18. Akhapkina V.I., Voronina T.A. Spektr farmakologicheskikh effektov fenotropila. Novye lekarstvennye sredstva i tekhnologii. Farmateka 2005; 13: 19-24.
  19. Kovalev G.I., Akhapkina V.I., Abaimov D.A., Firstova Yu.Yu. Fenotropil kak retseptornyi modulyator sinapticheskoi neiroperedachi. Atmosfera. Nervnye bolezni 2007; 3: 22-26.
  20. Akhapkina V.I., Fedin A.I., Avedisova A.S., Akhapkin R.V. Effektivnost' fenotropila pri lechenii astenii i sindroma khronicheskoi ustalosti. Atmosfera. Nervnye bolezni 2004; 3: 28-32.
  21. Akhapkina V.I., Akhapkin R.V. Fundamental'nye osnovy modulyatornoi kontseptsii i klassifikatsiya modulyatornykh lekarstvennykh sredstv. Rus med zhurn 2012; 19: 933-951.
  22. Akhapkin R.V., Akhapkina V.I. Modulyatornaya kontseptsiya kak innovatsionnoe napravlenie v meditsine. Rus med zhurn 2012; 19: 952-959.
  23. Florey E. Neurotransmitters and modulators in the animal kingdom. Federation Proc 1967; 26: 1164-1178.
  24. Pfluger H.-J., Buschges A. Neuromodulation of Microcircuits in Motor Systems: Invertebrates. Report of the 93rd Dahlem Workshop on Microcircuits: The Interface between Neurons and Global Brain Function. Berlin 2004; 60.
  25. Kadykov A.S., Shakhparonova N.V., Kashina E.M. Astenicheskie sostoyaniya v klinike sosudistykh zabolevanii golovnogo mozga i vozmozhnosti ikh korrektsii. Nervnye bolezni 2012; 1: 24-28.
  26. Mokina T.V., Antipenko E.A., Gustov A.V. Effektivnost' Fenotropila pri lechenii astenicheskogo sindroma u bol'nykh distsirkulyatornoi entsefalopatiei. Lechebnoe delo 2010; 4: 68-72.
  27. Gerasimova M.M., Chichanovskaya L.V., Bardukova E.A., Dorenskaya O.V., Solov'eva A.V. Effektivnost' Fenotropila pri khronicheskoi ishemii golovnogo mozga. Klinicheskaya nevrologiya 2008; 4: 34-38.
  28. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 3: 315-325.
  29. Lin J.M., Brimmer D.J., Maloney E.M., Nyarko E., BeLue R., Reeves W.C. Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr 2009; 7: 18.
  30. Yakhno N.N., Zakharov V.V., Lokshina A.B. Narusheniya pamyati i vnimaniya v pozhilom vozraste. Zhurn nevrol i psikhiat 2006; 106: 2: 58-62.
  31. Putilina M.V., Radishevskii M.V., Batoroeva Ts.S. Astenicheskie sindromy pri khronicheskoi ishemii mozga i ikh korrektsiya. Nevrol i revmatol (Prilozhenie k zhurnalu Consilium Medicum) 2012; 2: 22-25.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.